A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/00 (2006.01) A61K 31/16 (2006.01) A61K 31/409 (2006.01) A61K 31/435 (2006.01) A61K 33/26 (2006.01) A61K 38/17 (2006.01) A61K 38/44 (2006.01) A61K 45/06 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2490392
The present invention relates to the treatment of disorders using nitric oxide (NO), heme oxygenase-1 (HO-1) and heme degradation products such as carbon monoxide (CO), biliverdin, bilirubin and iron.
L'invention concerne le traitement de certains troubles par le monoxyde d'azote (NO), l'hème oxygénase-1 (HO-1) et les produits de dégradation de l'hème, tels que le monoxyde de carbone (CO), la biliverdine, la bilirubine et le fer.
Bach Fritz H.
Otterbein Leo E.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Beth Israel Deaconess Medical Center Inc.
University Of Pittsburgh Of The Commonwealth System Of Higher Ed
LandOfFree
Pharmaceutical use of nitric oxide, heme oxygenase-1 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical use of nitric oxide, heme oxygenase-1 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical use of nitric oxide, heme oxygenase-1 and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1645963